CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

F. Zaja, V. Tabanelli, C. Agostinelli, A. Calleri, A. Chiappella, M. Varettoni, P. Luigi Zinzani, S. Volpetti, E. Sabattini, R. Fanin, S. A. Pileri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)E1-E2
JournalAmerican Journal of Hematology
Issue number1
Publication statusPublished - Jan 1 2017


  • ADP-ribosyl Cyclase 1/biosynthesis
  • B7-H1 Antigen/biosynthesis
  • Drug Delivery Systems/methods
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lymphoma, T-Cell, Peripheral/drug therapy/metabolism/pathology
  • Male
  • Membrane Glycoproteins/biosynthesis
  • Programmed Cell Death 1 Receptor/biosynthesis
  • Proto-Oncogene Proteins c-bcl-2/biosynthesis

Cite this